Moderna leads development of mRNA vaccines in infectious diseases: GlobalData
Moderna has Phase III pipeline candidates in four different indications (COVID-19, influenza, RSV, and cytomegalovirus) and is…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Zydus gets USFDA nod for Gabapentin tablets (once-daily), 300 mg and 600 mg
Gabapentin is indicated for the management of Postherpetic Neuraligia (PHN)
STEER appoints TN Hari as Executive Chairman
Hari will set the strategic direction for STEER’s Engineering, Life Sciences and Materials businesses and oversee its…
Jiangsu Alphamab, 3D Medicines and Glenmark sign license pact for KN035 (Envafolimab)
Glenmark will be responsible for further developing, registering, and commercialising Envafolimab in India, Asia Pacific, Middle…
48 per cent of healthcare, pharma cos set to integrate first-Gen AI solution within next year: EY…
28 per cent surveyed have implemented their first GenAI solution, 60 per cent believe Gen AI will have a significant impact on the…
Siemens Healthineers, IISc launch laboratory for AI in precision medicine
The CDS collaborative laboratory will develop open-source AI-based tools to automate the segmentation of pathological findings in…
Venus Remedies gets GMP certification from Libya
This GMP certification has added to the company's portfolio of international approvals from 25 regulators
SII joins CEPI global network to boost production of affordable outbreak vaccines
CEPI is investing up to $30 million to expand the company’s existing capabilities and support rapid development of outbreak…
Lupin gets tentative US FDA approval for Rivaroxaban Tablets USP
This product will be manufactured at Lupin’s Pithampur facility in India
World’s first malaria vaccine rolled out in Cameroon
The vaccine, designed to be administered to young children in four doses from around five months of age, acts against P.…
Obesity care needs greater revolution: GlobalData
According to the KOLs interviewed by GlobalData, the diagnostic and management tools for obesity need to be updated and patients…
AstraZeneca receives CDSCO approval to import and market Andexanet Alfa in India
This drug is used for the treatment of critical bleeding conditions associated with use of novel anticoagulants (Factor Xa…
Bioprinting holds potential in shaping future of healthcare: GlobalData
The current global market for bioprinting is estimated to be valued at $1.7 billion in 2021 and is forecast to reach $5.3 billion…
Indian Immunologicals rolls out India’s first indigenously developed Hepatitis A Vaccine ‘Havisure’
It is a two-dose vaccine wherein the first dose is administered at above 12 months of age and the second dose is given at least…
Zydus, Synthon sign licensing and supply pact for Palbociclib Tablets for US market
Synthon will be responsible for obtaining US regulatory approval for Palbociclib Tablets, and thereafter, for the manufacturing…
Glenmark Life Sciences signs MSA with Japanese pharma company
To manufacture and supply API in the therapeutic area of urinary anti-spasmodic
Lupin gets US FDA nod for Febuxostat tablets
Febuxostat Tablets, 40 mg and 80 mg, are indicated for the chronic management of hyperuricemia in adult patients with gout who…
US FDA approves Casgevy, cell-based gene therapy to treat transfusion-dependent beta-thalassemia
The approval signifies a second FDA-approved indication for Casgevy, as the product was also recently approved for the treatment…
PDC*line Pharma, partners get €8.1mn from Walloon region, BioWin for personalised therapeutic…
Collaborative effort between biotech companies, PDC*line Pharma and OncoDNA, technology company salamanderU and universities…
Bayer, Sun Pharma sign marketing and distribution pact for second brand of Finerenone
Sun Pharma to market the drug under the brand name Lyvelsa